Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Evaluation of Treatment Durability Among Treatment-naive HIV-infected Individuals Initiated First-line ART in Russia

NCT04253119 is registered in ClinicalTrials.gov with MSD Pharmaceuticals LLC as lead sponsor.

NCT NCT04253119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04253119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Evaluation of Treatment Durability Among Treatment-naive HIV-infected Individuals Initiated First-line ART in Russia
Lead sponsor
MSD Pharmaceuticals LLC
Phase
Observational
Overall status
Completed
Start date
November 26, 2019
Completion date
June 30, 2022
Enrollment
536 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection